Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-28T18:23:28.416Z Has data issue: false hasContentIssue false
  • English
  • Français

Teamwork, Cooperation, Innovation: Clues in the Canadian Success of Stroke Care

Published online by Cambridge University Press:  04 July 2016

Gustavo Saposnik
Gustavo Saposnik*
Affiliation:
St. Michael's Hospital, University of Toronto, Toronto, Ontario, saposnikg@smh.toronto.on.ca
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 36 , Issue 2 , March 2009 , pp. 133 - 134
Copyright
Copyright © Canadian Neurological Sciences Federation 2009

References

1.Bogousslavsky, J, Pierre, P.Ischemic stroke in patients under age 45. Neurol Clin. 1992 Feb;10(1):113–24.CrossRefGoogle ScholarPubMed
2.Adams, HP Jr., del Zoppo, G, Alberts, MJ, Bhatt, DL, Brass, L, Furian, A, et al.Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007 May;38(5):1655–711.CrossRefGoogle ScholarPubMed
3.Wagner, JC, Lutsep, HL. Thrombolysis in young adults. J Thromb Thrombolysis. 2005 Oct;20(2): 133–6.Google Scholar
4.Poppe, A, Hill, M, AM, B. Intravenous thrombolysis for acute ischemic stroke in young adult patients. Can J Neurol Sci. 2009; 36:161–7.CrossRefGoogle Scholar
5.Hill, MD, Buchan, AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005 May 10; 172(10): 1307–12.Google Scholar
6.O'Donnell, MJ, Kapral, MK, Fang, J, Saposnik, G, Eikelboom, JW, Oczkowski, W, et al.Gastrointestinal bleeding after acute ischemic stroke. Neurology. 2008 Aug 26;71(9):650–5.Google Scholar
7.Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995 Dec 14;333(24): 1581–7.Google Scholar
8.Ringleb, PA, Schellinger, PD, Schranz, C, Hacke, W. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful? Stroke. 2002 May;33(5): 1437–41.Google Scholar
9.Fiorelli, M, Bastianello, S, von Kummer, R, et al.Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999 Nov;30(11):2280–4.Google Scholar
10.Clark, WM, Wissman, S, Albers, GW, Jhamandas, JH, Madden, KP, Hamilton, S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Jama. 1999 Dec 1;282(21):2019–26.Google Scholar
11.Hacke, W, Kaste, M, Bluhmki, E, Brozman, M, Davalos, A, Guidetti, D, et al.Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13): 1317–29.Google Scholar
12.Wahlgren, N, Ahmed, N, Davalos, A, Hacke, W, Milan, M, Muir, K, et al.Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008 Oct 11;372(9646): 1303–9.Google Scholar